Skip to content
Home/Companies/Biotech/Hummingbird

Hummingbird

Biotech·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Hummingbird?

Hummingbird is a French Biotech company, currently owned by Novo Holdings since 2021 and Omnes Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Omnes Capital
Most recent investor
Omnes Capital
Construction Energie Plus · 2016 · Buyout
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Omnes Capital and Novo Holdings since 2020.
Co-invest · 2 holders · 2020 · present
Omnes Capital
2020 · present(6yr) · Construction Energie Plus · 2016 · Buyout
Novo Holdings
2021 · present(5yr) · Novo Holdings Venture Investments · 1999 · VC

Questions

Who owns Hummingbird?

Hummingbird is currently owned by Novo Holdings and Omnes Capital, through Construction Energie Plus, since 2021.

When did Novo Holdings and 1 other acquire Hummingbird?

Novo Holdings and 1 other acquired Hummingbird in 2021.

Who has owned Hummingbird over time?

Hummingbird has been through 2 private-equity ownership periods: Omnes Capital · via Construction Energie Plus · since 2020; Novo Holdings · via Novo Holdings Venture Investments · since 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue